LYMPHOPENIA
Clinical trials for LYMPHOPENIA explained in plain language.
Never miss a new study
Get alerted when new LYMPHOPENIA trials appear
Sign up with your email to follow new studies for LYMPHOPENIA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New hope for cancer patients battling treatment side effect that lowers survival
Disease control AVAILABLEThis program provides expanded access to an investigational drug called nogapendekin-alfa inbakicept (NAI) for adults with solid tumors. It aims to treat low lymphocyte counts (lymphopenia), a common and serious side effect of chemotherapy, immunotherapy, or radiation that can re…
Matched conditions: LYMPHOPENIA
Sponsor: ImmunityBio, Inc. • Aim: Disease control
Last updated Mar 13, 2026 15:06 UTC
-
Fungus-Derived pill aims to rebuild cancer Patients' weakened immunity
Disease control Recruiting nowThis study is testing if a pill called PRaG-1 (cordycepin) can help restore a specific type of weakened immune cell in cancer survivors. It will involve about 127 adults who are free of solid tumors but have low CD8+ T-cell counts after finishing chemotherapy or radiation. Partic…
Matched conditions: LYMPHOPENIA
Phase: PHASE2 • Sponsor: Second Affiliated Hospital of Soochow University • Aim: Disease control
Last updated Mar 05, 2026 14:00 UTC
-
Cancer treatment may weaken vaccine protection, study investigates
Knowledge-focused Recruiting nowThis study aims to understand how radiation treatment for esophageal cancer affects patients' ability to respond to pneumonia vaccines. Researchers will compare vaccine responses in 80 cancer patients and healthy individuals to see if radiation weakens immune protection. The goal…
Matched conditions: LYMPHOPENIA
Sponsor: M.D. Anderson Cancer Center • Aim: Knowledge-focused
Last updated Mar 19, 2026 14:55 UTC